Daewon Pharmaceutical Co., Ltd.
Clinical trials sponsored by Daewon Pharmaceutical Co., Ltd., explained in plain language.
-
Two drugs beat one in cholesterol battle
Disease control CompletedThis completed study tested if a two-drug combination (DW5421A/DW5421B) works better than a single drug (DW5421A) at lowering 'bad' LDL cholesterol in adults with high cholesterol or mixed lipid problems. About 184 participants were randomly assigned to take either the combinatio…
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug trial aims to tame painful, heavy periods from fibroids
Disease control CompletedThis study tested an experimental drug called DW4902 to see if it could control symptoms of uterine fibroids, mainly heavy menstrual bleeding. It involved 71 premenopausal women who were randomly assigned to receive either the real drug or a placebo for 12 weeks. Researchers meas…
Phase: PHASE2 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
First human test for new cholesterol pill
Knowledge-focused CompletedThis was an early safety study to see how the body absorbs and processes two forms of a new drug candidate, DW5124, intended to treat mixed dyslipidemia (a cholesterol and fat disorder). It involved 55 healthy adult volunteers to check for side effects and see if taking the drug …
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test if food changes how your body handles a new heartburn drug
Knowledge-focused CompletedThis early-stage study tested how eating food affects the way a new medication for acid reflux (GERD) is absorbed and processed by the body. It involved 24 healthy adult volunteers who took the drug, called DW4421, with and without food. The main goal was to measure the drug's le…
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC